The African Union (AU) has dropped plans to secure coronavirus vaccines from the Serum Institute of India because of supply concerns and is instead exploring options with the US drugmaker, Johnson & Johnson. The head of Africa’s Centres for Disease Control, John Nkengasong, said reliable supplies of vaccines were vital – and that Indian restrictions on exports had complicated things for Africa. He added that the AU’s decision had nothing to do with the possible link to blood clots in rare cases involving the Oxford-AstraZeneca vaccine which will still be supplied to Africa through the UN’s Covax scheme. India’s Serum Institute is licensed to make global supplies of AstraZeneca but Delhi has commandeered stocks to deal with surging infections. Mr Nkengasong said the AU had already signed a deal for up to 400 million single dose jabs from Johnson & Johnson.
SOURCE: BBC
More Stories
Top 5 African Travel Destinations To Visit This August
African Countries that don’t Require a Visa to Enter South Africa
South Africans are Now Swelling the Ranks of Explorers Shouldering Backpacks
Getting around West Africa’s Most Populous City can be an Adventure in Itself
The Mauritian Dream
The Newly Reopened Africa Centre Celebrates the Continent’s Culture (and Seriously Chic Room Dividers)
From Bold Prints to Gender Defying Clothes: 4 Things to Know About Contemporary African Fashion
Meet the Nigerian Artist Visualizing Africa’s Future by Reaching into the Past
En Vogue
Interview: Director K is Making Historic Afrobeats Music Videos
Nigeria has Promised to Legalize Local Refineries and Set Up Refining Hubs in the Niger Delta
Central African Ministers Agree to Merge Two Regional Blocs to Boost Trade and Growth